News

Healthcare, Life Sciences

Sonomind lève 20 millions d'euros pour transformer le traitement de la dépression résistante
26/05/2026

Sonomind closes a 20 million euro Series A to revolutionise the treatment of resistant depression

Mental health is one of the major medical challenges of the coming decades. And yet, for 30% to 50% of patients around the world, the treatments available simply do not work. It is precisely this therapeutic dead end that Sonomind intends to break through. With a 20 million euro Series A closed in May 2026, […]

Levée de fonds dans la santé numérique : Axomove lève 4 millions d’euros
15/05/2026

Digital Health Funding: Axomove Raises €4 Million

Lille-based medtech company Axomove has announced a €4 million Series A funding round led by Bpifrance and Go Capital. The transaction highlights both the growing momentum behind digital medical devices and the increasing appetite of institutional investors for the sector. Analysis and insights by the experts at AURIS Finance, advisory firm specializing in M&A, fundraising, […]

Stereotaxis acquiert Robocath : une innovation française de la robotique cardiaque passe sous pavillon américain
06/05/2026

Stereotaxis acquires Robocath: a French cardiac robotics innovation moves under U.S. ownership

In April 2026, Stereotaxis, listed on the NYSE, announced the acquisition of Rouen-based start-up Robocath for up to $45 million. This transatlantic transaction highlights both the maturity of the French medtech ecosystem and the financing challenges faced by European deeptech companies in scaling up. Insights and analysis by the experts at AURIS Finance, an M&A […]

NeuroClues lève 10 millions d’euros et accélère l’industrialisation de sa solution
27/04/2026

NeuroClues raises €10 million to accelerate the industrialization of its solution

The momentum of French MedTech companies continues with NeuroClues’ latest fundraising round. The start-up, which specializes in ocular biomarkers for neurological diagnosis, has announced a new €10 million financing round. This funding transaction will enable NeuroClues to enter a key industrialization phase built around artificial intelligence and accelerate its international expansion. Insights and analysis by […]

Infirmière réalisant une piqure d'insuline, pour illustrer la levée de fonds de DiappyMed aux côtés de Ventech & Sanofi
02/04/2026

Fundraising: DiappyMed accelerates with Ventech and enters into a strategic partnership with Sanofi

A new milestone for the Montpellier-based MedTech company. DiappyMed, a specialist in digital therapies for diabetes, is scaling up its operations. The start-up has successfully completed a €5 million seed funding round led by Ventech and has also announced a strategic partnership with Sanofi. An analysis by the experts at AURIS Finance, a leading M&A […]

biotechs biotech
24/03/2026

Biotech funds back in search of performance

After years marked by high capital costs and a pronounced risk aversion among investors, a new cycle is emerging for biotech companies, as evidenced by the resurgence of merger and acquisition activity. Insights and analysis by the experts at AURIS Finance, a corporate finance advisory firm specialising in mergers and acquisitions. In 2025, the Nasdaq […]

See More